HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient.

AuthorsMatthew McCord, Rimas V Lukas, Christina Amidei, Nathan Demars, Arnold Gelb, Jill Buck, Sean Sachdev, Alexander Feldman, Matthew Tate, Karan Dixit, Daniel J Brat, Lawrence Jennings, Craig Horbinski
JournalNeuro-oncology advances (Neurooncol Adv) 2021 Jan-Dec Vol. 3 Issue 1 Pg. vdab045 ISSN: 2632-2498 [Electronic] England
PMID34250480 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: